Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics

被引：0

作者：

Jang, Hyemin ^{[1
]}

Shin, Daeun ^{[2
]}

Yoo, Heejin ^{[2
]}

Zetterberg, Henrik ^{[3
,4
,5
,6
,7
,8
]}

Blennow, Kaj ^{[3
,4
,9
,10
,11
,12
]}

Gonzalez-Ortiz, Fernando ^{[3
,4
]}

Ashton, Nicholas J. ^{[3
,13
,14
,15
,16
]}

Day, Theresa A. ^{[17
]}

Lee, Eun Hye ^{[2
]}

Yun, Jihwan ^{[18
]}

Na, Duk L. ^{[2
]}

Kim, Hee Jin ^{[2
,19
,20
,21
]}

Kang, Sung Hoon ^{[22
]}

Kim, Ko Woon ^{[23
]}

Kim, Si Eun ^{[24
]}

Kim, Yeo Jin ^{[25
]}

Kim, Yeshin ^{[26
]}

Kim, Jaeho ^{[27
]}

Kim, Chi-Hun ^{[28
]}

Chun, Min Young ^{[29
,30
]}

Jung, Na Yeon ^{[31
]}

Cho, Soo Hyun ^{[32
]}

Kim, Jun Pyo ^{[2
]}

Seo, Sang Won ^{[2
,19
,20
,21
]}

K-ROAD Study Grp

机构：

[1] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul Natl Univ Hosp, Seoul, South Korea

[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea

[3] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden

[4] Sahlgrens Univ Hosp, Clin Neurochem Lab, Gothenburg, Sweden

[5] UCL, Dept Neurodegenerat Dis, Inst Neurol, Queen Sq, London, England

[6] UCL, UK Dementia Res Inst, London, England

[7] Hong Kong Ctr Neurodegenerat Dis, Clear Water Bay, Hong Kong, Peoples R China

[8] Univ Wisconsin Madison, Wisconsin Alzheimers Dis Res Ctr, Univ Wisconsin Sch Med & Publ Hlth, Madison, WI USA

[9] Sorbonne Univ, Pitie Salpetriere Hosp, Paris Brain Inst, ICM, Paris, France

[10] Univ Sci & Technol China, Affiliated Hosp USTC 1, Inst Aging & Brain Disorders, Hefei, Peoples R China

[11] Univ Sci & Technol China, Inst Aging & Brain Disorders, Dept Neurol, Hefei, Peoples R China

[12] USTC, Affiliated Hosp 1, Hefei, Peoples R China

[13] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Inst Psychiat Psychol & Neurosci, De Crespigny Pk, London, England

[14] South London & Maudsley NHS Fdn Trust, NIHR Biomed Res Ctr Mental Hlth, De Crespigny Pk, London, England

[15] South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, De Crespigny Pk, London, England

[16] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway

[17] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN USA

[18] Soonchunhyang Univ, Bucheon Hosp, Dept Neurol, Bucheon Si, Gyeonggi Do, South Korea

[19] Samsung Med Ctr, Alzheimers Dis Convergence Res Ctr, Seoul, South Korea

[20] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea

[21] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea

[22] Korea Univ, Coll Med, Dept Neurol, Guro Hosp, Seoul, South Korea

[23] Jeonbuk Natl Univ, Med Sch & Hosp, Dept Neurol, Jeonju Si, South Korea

[24] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Neurol, Busan, South Korea

[25] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Neurol, Seoul, South Korea

[26] Kangwon Natl Univ, Sch Med, Kangwon Natl Univ Hosp, Dept Neurol, Chuncheon Si, Gangwon Do, South Korea

[27] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Neurol, Seoul, South Korea

[28] Hallym Univ, Coll Med, Dept Neurol, Sacred Heart Hosp, Anyang Si 431070, Gyeonggi Do, South Korea

[29] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea

[30] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Dept Neurol, Yongin, Gyeonggi Do, South Korea

[31] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Dept Neurol, Yangsan Si, Gyeongsangnam D, South Korea

[32] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Neurol, Gwangju, South Korea

来源：

ALZHEIMERS & DEMENTIA | 2025年 / 21卷 / 02期

基金：

瑞典研究理事会; 新加坡国家研究基金会;

关键词：

Alzheimer's disease; neurofilament light chain; positron emission tomography; plasma biomarker; p-tau217; PHOSPHORYLATED TAU 181; NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; PROTEIN;

D O I：

10.1002/alz.14526

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

INTRODUCTION This study aimed to investigate the differential roles of various plasma biomarkers in a stepwise diagnostic strategy for Alzheimer's disease (AD). METHODS A total of 2984 participants, including 666 cognitively unimpaired (CU), 2032 with Alzheimer's clinical syndrome (ACS), and 286 non-ACS individuals, were recruited. Plasma amyloid beta (A beta) 42/40, four phosphorylated tau (p-tau) epitopes, glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) levels were measured using immunoassays. RESULTS NfL demonstrated fair to excellent accuracy in differentiating non-ACS from CU groups (area under the curve [AUC], 0.79 to 0.94). p-tau217 had the highest accuracy for identifying A beta (AUC 0.94) and tau positron emission tomography status (AUC 0.91). In the ACS group, p-tau217 was the strongest predictor of cognitive decline (p < .001). DISCUSSION NfL may serve as a useful screening tool, while p-tau217 is particularly valuable for confirming AD pathology and prognosis.

引用

页数：12

共 50 条

[31] Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
Toniolo, Sofia
Zhao, Sijia
Scholcz, Anna
Amein, Benazir
Ganse-Dumrath, Akke
Heslegrave, Amanda J.
Thompson, Sian
Manohar, Sanjay
Zetterberg, Henrik
Husain, Masud
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2024, 16 (02)
[32] Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease
Leuzy, Antoine
Cullen, Nicholas C.
Mattsson-Carlgren, Niklas
Hansson, Oskar
CURRENT OPINION IN NEUROLOGY, 2021, 34 (02) : 266 - 274
[33] An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
Palmqvist, Sebastian
Stomrud, Erik
Cullen, Nicholas
Janelidze, Shorena
Manuilova, Ekaterina
Jethwa, Alexander
Bittner, Tobias
Eichenlaub, Udo
Suridjan, Ivonne
Kollmorgen, Gwendlyn
Riepe, Matthias
von Arnim, Christine A. F.
Tumani, Hayrettin
Hager, Klaus
Heidenreich, Fedor
Mattsson-Carlgren, Niklas
Zetterberg, Henrik
Blennow, Kaj
Hansson, Oskar
ALZHEIMERS & DEMENTIA, 2023, 19 (04) : 1204 - 1215
[34] Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers
Alvarez-Sanchez, Lourdes
Pena-Bautista, Carmen
Ferre-Gonzalez, Laura
Cubas, Laura
Balaguer, Angel
Casanova-Estruch, Bonaventura
Baquero, Miguel
Chafer-Pericas, Consuelo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
[35] Plasma Biomarkers of Alzheimer's Disease in African Americans
Deniz, Kaancan
Ho, Charlotte C. G.
Malphrus, Kimberly G.
Reddy, Joseph S.
Nguyen, Thuy
Carnwath, Troy P.
Crook, Julia E.
Lucas, John A.
Graff-Radford, Neill R.
Carrasquillo, Minerva M.
Ertekin-Taner, Nilufer
JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (01) : 323 - 334
[36] YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer's Disease
Mavroudis, Ioannis
Chowdhury, Rumana
Petridis, Foivos
Karantali, Eleni
Chatzikonstantinou, Symela
Balmus, Ioana Miruna
Luca, Iuliana Simona
Ciobica, Alin
Kazis, Dimitrios
MEDICINA-LITHUANIA, 2022, 58 (01):
[37] Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning
Xu, Amy
Kouznetsova, Valentina L.
Tsigelny, Igor F.
JOURNAL OF ALZHEIMERS DISEASE, 2022, 86 (02) : 841 - 859
[38] Microbiosensor for Alzheimer's disease diagnostics: detection of amyloid beta biomarkers
Prabhulkar, Shradha
Piatyszek, Rudolph
Cirrito, John R.
Wu, Ze-Zhi
Li, Chen-Zhong
JOURNAL OF NEUROCHEMISTRY, 2012, 122 (02) : 374 - 381
[39] Neurogranin in Alzheimer's Disease: Roles in synaptic function, pathology, and potential as a diagnostic biomarker
Bavaharini, Rajkumar
Somala, Chaitanya Sree
Saravanan, Konda Mani
Anand, Thirunavukarasou
AIMS MOLECULAR SCIENCE, 2024, 11 (04): : 330 - 350
[40] A Fragment of S38AA is a Novel Plasma Biomarker of Alzheimer's Disease
Hashimoto, Masakazu
Yamazaki, Akira
Ohno, Atsushi
Kimura, Toru
Winblad, Bengt
Tjernberg, Lars O.
JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (04) : 1163 - 1174

← 1 2 3 4 5 →